Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2007 Mar;22(3):362-7.
doi: 10.1007/s11606-006-0099-7.

Improving care of patients at-risk for osteoporosis: a randomized controlled trial

Daniel H Solomon  1 , Jennifer M Polinski, Margaret Stedman, Colleen Truppo, Laura Breiner, Catherine Egan, Saira Jan, Minal Patel, Thomas W Weiss, Ya-ting Chen, M Alan Brookhart
Affiliations
Randomized Controlled Trial

Improving care of patients at-risk for osteoporosis: a randomized controlled trial

Daniel H Solomon et al. J Gen Intern Med. 2007 Mar.

Abstract

Background: Despite accurate diagnostic tests and effective therapies, the management of osteoporosis has been observed to be suboptimal in many settings. We tested the effectiveness of an intervention to improve care in patients at-risk of osteoporosis.

Design: Randomized controlled trial.

Participants: Primary care physicians and their patients at-risk of osteoporosis, including women 65 years and over, men and women 45 and over with a prior fracture, and men and women 45 and over who recently used > or =90 days of oral glucocorticoids.

Intervention: A multifaceted program of education and reminders delivered to primary care physicians as well as mailings and automated telephone calls to patients.

Outcome: Either undergoing a bone mineral density (BMD) testing or filling a prescription for a bone-active medication during the 10 months of follow-up.

Results: After the intervention, 144 (14%) patients in the intervention group and 97 (10%) patients in the control group received either a BMD test or filled a prescription for an osteoporosis medication. This represents a 4% absolute increase and a 45% relative increase (95% confidence interval 9-93%, p = 0.01) in osteoporosis management between the intervention and control groups. No differences between groups were observed in the incidence of fracture.

Conclusion: An intervention targeting primary care physicians and their at-risk patients increased the frequency of BMD testing and/or filling prescriptions for osteoporosis medications. However, the absolute percentage of at-risk patients receiving osteoporosis management remained low.

PubMed Disclaimer

Figures

Figure 1
Figure 1
This flow chart shows how the study population was assembled.
See this image and copyright information in PMC

References

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1111/j.1525-1497.2004.30240.x', 'is_inner': False, 'url': 'https://doi.org/10.1111/j.1525-1497.2004.30240.x'}, {'type': 'PMC', 'value': 'PMC1492483', 'is_inner': False, 'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC1492483/'}, {'type': 'PubMed', 'value': '15209594', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15209594/'}]}
    2. Morris CA, Cabral D, Cheng H, et al. Patterns of bone mineral density testing: current guidelines, testing rates, and interventions. J Gen Intern Med. 2004;19:783–90. - PMC - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '15704774', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15704774/'}]}
    2. Solomon DH, Morris C, Cheng H, et al. Medication use patterns for osteoporosis: an assessment of guidelines, treatment rates, and quality improvement interventions. Mayo Clin Proc. 2005;80:194–202. - PubMed
    1. http://www.ncqa.org/communications/sohc2004/osteoporosis.htm accessed November 21, 2005.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1002/art.10787', 'is_inner': False, 'url': 'https://doi.org/10.1002/art.10787'}, {'type': 'PubMed', 'value': '12522840', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/12522840/'}]}
    2. Harrington JT, Broy SB, DeRosa AM, Licata AA, Shewmon, DA. Hip fracture patients are not treated for osteoporosis: a call for action. Arthritis Care Res. 2002;47:651–4. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1002/1529-0131(199908)42:8<1736::AID-ANR24>3.0.CO;2-E', 'is_inner': False, 'url': 'https://doi.org/10.1002/1529-0131(199908)42:8<1736::aid-anr24>3.0.co;2-e'}, {'type': 'PubMed', 'value': '10446875', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/10446875/'}]}
    2. Buckley LM, Marquez M, Feezor R, Ruffin DM, Benson LL. Prevention of corticosteroid induced osteoporosis: results of a patient survey. Arthritis Rheum. 1999;42:1736–9. - PubMed

Publication types